Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.indianpharmapost.com/news/syngene-biologics-facility-to-be-operational-for-us-european-customers-from-mid-year-15406
https://www.prnewswire.com/news-releases/syngene-biologics-manufacturing-facility-to-be-operational-for-us-and-european-customers-from-mid-year-302089768.html
https://www.indianpharmapost.com/news/syngene-q3-fy-24-pat-up-4-to-rs-115-cr-15201
https://www.indianpharmapost.com/news/stelis-biopharma-updates-on-receipt-of-consideration-from-syngene-15058
https://www.indianpharmapost.com/news/syngene-concludes-acquisition-of-biologics-manufacturing-facility-from-stelis-biopharma-14961
https://www.indianpharmapost.com/news/syngene-q2-fy23-24-revenue-from-operations-up-185-to-rs-910-cr-14797
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/strides-sells-arms-manufacturing-unit-to-syngene-international-for-rs-702-crore/articleshow/101496266.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/syngene-international-sees-strong-momentum-this-fiscal-year-md/articleshow/100082312.cms
https://www.marketscreener.com/quote/stock/SYNGENE-INTERNATIONAL-LIM-46731329/news/Syngene-International-Gets-Zero-Observations-from-US-FDA-for-Biologics-Facility-in-India-42316347/
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/syngene-reports-rs-102-crore-net-profit-in-q2fy23/articleshow/94971032.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst